Find your next paid study

Public Health Foundation Enterprises, Inc.NCT06631365

~$75 – $1,800

Actual pay is set by the research site.

Effect of Environment on the Central and Peripheral Nervous System

The main goal of this study is to understand how different environments influence both mental responses, like overthinking (rumination), and physical reactions…

Rumination

University of South FloridaNCT06778356

Actual pay is set by the research site.

Phase 3

Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG). T…

Myasthenia Gravis

Janssen Research & Development, LLCNCT04951622

~$50 – $2,100

Actual pay is set by the research site.

Phase 3

A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Children and Adolescents From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis

The purpose of this study is to evaluate the drug levels, efficacy, and safety of Deucravacitinib (BMS-986165) in pediatric participants with juvenile psoriati…

Juvenile Psoriatic Arthritis

Bristol-Myers SquibbNCT06869551

~$50 – $2,250

Actual pay is set by the research site.

Spinal FusionSpinal Stenosis

Pulse-width Modulation During Pedicle Screw Stimulation

The overarching aim of this project is to modulate the pulse-width during stimulation of pedicle screws and record the response thresholds associated with each…

Dartmouth-Hitchcock Medical CenterNCT06120231

Actual pay is set by the research site.

Robot-Aided Diagnosis, Passive-Active Arm Motor and Sensory Rehabilitation Post Stroke: Aims 2&3

Sensorimotor impairments following stroke often involve complex pathological changes across multiple joints and multiple degrees of freedom of the arm and hand…

Stroke

University of Maryland, BaltimoreNCT02359253

Actual pay is set by the research site.

Phase 2

Phase II Study of CIMAVAX-EGF in Combination With KRAS G12C Inhibitors as Treatment for Advanced Stage KRAS G12C Mutated NSCLC

This phase II trial tests how well giving CIMAvax-EGF with KRAS G12C inhibitor (sotorasib or adagrasib) for the treatment of patients with KRAS G12C mutated no…

Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8

Roswell Park Cancer InstituteNCT07543172

~$75 – $3,000

Actual pay is set by the research site.

Phase 2

A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myeloid Malignancies

This study will evaluate whether processing blood stem cell transplants using an investigational device (the CliniMACS system) results in less complications fo…

Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute

Guenther KoehneNCT05565105

~$75 – $3,000

Actual pay is set by the research site.

Phase 1

A Phase Ib/II, Open-label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic Breast Cancer (Morpheus-panBC)

This is an umbrella study evaluating the efficacy and safety of multiple treatment combinations in participants with metastatic or inoperable locally advanced …

Metastatic Breast Cancer

Hoffmann-La RocheNCT03424005

~$150 – $4,500

Actual pay is set by the research site.

EpilepsyBrain Tumor Adult

Neuronal and Network Mechanisms of Electrocortical Stimulation

Electrocortical stimulation (ECS) mapping is a procedure used during brain surgeries, for example when treating diseases like epilepsy or when removing brain t…

Northwestern UniversityNCT06391294

Actual pay is set by the research site.

Phase 4

An Open Label, Multi-center Asciminib Roll-over Study to Assess Long-term Safety in Patients Who Have Completed a Novartis Sponsored Asciminib Study and Are Judged by the Investigator to Benefit From Continued Treatment

This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from contin…

Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive

Novartis PharmaceuticalsNCT04877522

~$25 – $1,400

Actual pay is set by the research site.

Phase 1

Phase I Pilot Trial of Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas

This research study is for people who have been diagnosed with large B-cell lymphoma of the central nervous system (CNS), which has either returned or is not r…

Large B-cell LymphomaCentral Nervous System Lymphoma